Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Xerri

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Leukemia|March 31, 2006
t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia veraA Murati, J Adélaïde, V Gelsi-Boyer, et al.
Blood|May 29, 2000
Expression of gene MAGE-A4 in Reed-Sternberg cellsH Chambost, N Van Baren, F Brasseur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphomaT Rüdiger, R D Gascoyne, E S Jaffe, et al.
Leukemia|June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patientsR Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
The American Journal of Medicine|December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypesJ Gabarre, M Raphael, E Lepage, et al.
Leukemia|July 22, 2005
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocationA Murati, V Gelsi-Boyer, J Adélaïde, et al.
Oncogene|July 5, 2006
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancerA Letessier, S Garrido-Urbani, C Ginestier, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Blood Cancer Journal|April 22, 2017
EZH2 alterations in follicular lymphoma: biological and clinical correlationsS Huet, L Xerri, B Tesson, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Leukemia|March 31, 2006
t(5;12)(q23-31;p13) with ETV6-ACSL6 gene fusion in polycythemia veraA Murati, J Adélaïde, V Gelsi-Boyer, et al.
Blood|May 29, 2000
Expression of gene MAGE-A4 in Reed-Sternberg cellsH Chambost, N Van Baren, F Brasseur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2002
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphomaT Rüdiger, R D Gascoyne, E S Jaffe, et al.
Leukemia|June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patientsR Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
The American Journal of Medicine|December 19, 2001
Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypesJ Gabarre, M Raphael, E Lepage, et al.
Leukemia|July 22, 2005
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocationA Murati, V Gelsi-Boyer, J Adélaïde, et al.
Oncogene|July 5, 2006
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancerA Letessier, S Garrido-Urbani, C Ginestier, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Blood Cancer Journal|April 22, 2017
EZH2 alterations in follicular lymphoma: biological and clinical correlationsS Huet, L Xerri, B Tesson, et al.
Pageof 14